A preclinical study has analyzed the interactions of the lipid mediator sphingosine-1-phosphate (S1P) in the spleen and heart during the transition from acute to chronic heart failure. Using a mouse model of heart failure, the researchers discovered new mechanisms to help define how the spleen and heart coordinate physiological inflammation in cardiac repair.
